Acamprosate, a drug used to treat alcohol abuse, improves communication and social behaviors associated with a common form of autism. IU autism researcher Craig Erickson, MD, will discuss his ongoing study of acamprosate and Fragile X syndrome, the most frequent, single genetic cause of autism. Listen or download podcast Dr. Erickson is assistant professor of
A discussion for parents of children with special developmental needs about evidence, consensus and anecdotal-based interventions. After more than four decades of working with parents of children with special developmental needs, I’ve learned that they often find it difficult to know what the best approaches or interventions are to help their children. Conflicting statements, recommendations
Posted on September 8, 2017
Autism, Behavior, Clinical Practices, Consensus Documents, Daily Living Strategies, Education, Financial Resources, Fragile X Clinics, Fragile X Syndrome, FXPOI, FXTAS, Genetics, Guidelines, Hyperarousal, Medication, Research, Seizures, Sensory Integration, Sleeping, Toilet Training, Treatment and Intervention
FXCRC and Clinics / Treatment and Intervention
The Guidelines represent expert consensus and not evidence-based studies. The clinical committee of the Fragile X Clinical & Research Consortium (FXCRC) could be thought of as a “consensus panel” since virtually every clinician in the USA seeing and managing a large number of patients with Fragile X syndrome and other Fragile X-associated Disorders is represented.
Nov 2, 2017 4PM PT | 5PM MT | 6PM CT | 7PM ET Dr. Craig Erickson is back for the fifth time for our ever-popular subject: Medication for individuals living with Fragile X syndrome. The webinar will be a Q&A session during which you can submit your questions to Dr. Erickson. Space is limited